Abstract Opioids significantly alter functional responses of lymphocytes following activation. The opiate Morphine, alters the Th1 to Th2 response and modulates functional responses such as cytolytic activity and T-cell proliferation. Although there has been extensive research involving morphine's effects on lymphocytes, little is known about the effects morphine has on lymphocyte trafficking. The objective of the study was to use in vivo bioluminescent imaging to determine morphine's effect on the trafficking pattern of splenocytes systemically and into the CNS either in a naïve state or following a neuroinflammatory stimulus. A neuroinflammatory response was induced by intracerebrally administering a DNA IFN-γ DNA plasmid into morphinedependent or placebo wildtype mice. Mice with or without a neurostimulus received adoptively transferred firefly luciferase transgenic splenocytes and imaged. Morphine dependence significantly altered the inherent ability of splenocytes to traffic into the spleen, and lead to non-directed chaotic trafficking throughout the animal, including into the CNS. The morphine-mediated effects on trafficking were blocked by the antagonist naltrexone. Morphine dependence intensified splenocyte infiltration into the CNS following neuroinflammation induced by IFN-γ gene transfer. The study precented determined that morphine severely altered the ability of non-activated splenocytes to home to the spleen, inducing extrasplenic trafficking thoughout the animal. In addition to altering the ability of naive splenocyte to traffic to the spleen, this study demonstrated that morphine profoundly exacerbated lymphocyte infiltration into the CNS following a neurostimulus.
Introduction
Neuroinflammation induced by infectious diseases such as HIV leads to an increase of immune cells trafficking into the central nervous system (CNS) (Wu et al. 2000; Shacklett et al. 2004) . Lymphocyte trafficking to CNS is accomplished through three separate pathways; (1) extravasation across the choroid-plexus stroma (Carriters et al. 2002; Svenningsson et al. 1995) ; (2) through the carotid artery into the subarachnoid space and Virchow-Robin perivascular space (Hickey and Kimura 1988; Hickey et al. 1991; Lassmann et al. 1993) , and (3) directly into the parenchyma through the intact blood brain barrier (Hickey 1999; Wekerle and Fierz 1985) .
Lymphocyte trafficking to sites of infection is an imperative function for the initiation of an immune response (Von Andrian and Mackay 2000) . Many substances are capable of modulating lymphocyte responses to infections, including drugs of abuse (Friedman et al. 2003; Friedman and Eisenstein 2004; Roy et al. 2004) . Opiates and opioids act on the immune system through the central pathway, acting on the hypothalamo-pituitary-adrenal axis, the sympathetic nervous system, or directly on immune cells (Friedman et al. 2003) via opioid receptors such as delta, mu-, or kappa receptors. While the three receptors are responsive and influence immune responses, their expression levels are not homogeneous among all cells, and may differ upon activation (Benard et al. 2010) . The delta and mu-receptors are absent on resting T cells, but they are upregulated upon activation (Roy et al. 1991; Nguyen and Miller 2002; Jaume et al. 2007; Madden et al. 2001; Kraus et al. 2001; Borner et al. 2008) .
Chronic treatment with morphine suppresses immune functions such as phagocytosis (Szabo et al. 1995) , T-and B-lymphocyte proliferative response to mitogens (Bryant et al. 1991) , natural killer activity (Gomez- Flores and Weber 1999; Olin et al. 2004; Yokota et al. 2000) . While the effects of morphine on lymphocyte function have been well characterized, little is known involving morphine's effect on lymphocyte trafficking (Flores et al. 1995) .
Researchers have been able to track "in vivo" the effects of cancer treatments by using bioluminescent technology based on transgenic mice expressing firefly luciferase (Sweeney et al. 1999; Rauch et al. 2009 ). When the animal is injected with d-luciferin (the substrate for luciferase), photon emission will be proportional to the location and amount of viable cells, including cells within the CNS (Ohlfest et al. 2005) . The overall goal of this study was to use bioluminescent imaging to determine the effect of morphine dependence on splenocyte trafficking, with or without a neuroinflammatory stimulus. Morphine dependence significantly alters extrasplenic trafficking throughout the animal, including into the CNS.
Materials and methods
Mice Transgenic FVB mice containing a CMV-[beta]-actin promoter (Niwa et al. 1991 ) and a biscistronic gene consisting of two reporter genes, firefly (fFL) luciferase and enhanced green fluorescence protein (eGFP) (Ohlfest et al. 2004 ) was used as source splenocytes. Wildtype FVB mice were purchased from the Jackson Laboratory (Bar Harbor, Maine). All animals were housed and cared for under specific pathogen free conditions in accordance with the University of Minnesota Institutional Animal Care and Committee.
Morphine Mice were implanted subcutaneously with either a placebo pellet or a 75 mg morphine sulfate pellet 24 h prior to experiment. In experiments testing opiate specificity, the opiate mu-receptor antagonist naltrexone (34 mg) pellet was implanted in conjunction with a morphine pellet as previously described (Roy et al. 2005) .
IFNγ plasmid inoculation Animals were deeply anesthetized with a ketamine/xylazine cocktail solution (53.7 mg/ml ketamine, 9.26 mg/ml xylazine) delivered at a concentration of 1 ml/kg. Gene delivery of pKT2/CLP-mIFN-γ / polyethylenimine (PEI) complexes, pKT2/CLP empty vector / polyethylenimine (PEI) complexes control, were inoculated into the lateral ventricles was accomplished by slow infusion into the coordinates; 1 mm to the right, 0.5 mm posterior of the bregma, and 3.3 mm deep from the cortical surface of the brain. A final volume of 5 μl was infused over 20 min (flow rate: 0.1 μl/min) using a microinjection pump (CM100, Carnegie Medicine, Stockholm, Sweden). DNA/PEI complexes were prepared as described (Wu et al. 2007) ; seven equivalents of PEI were used per μg of DNA to generate the complexes. A total dose of 2.5 of DNA was administered, as described by (Sweeney et al. 1999; Wu et al. 2007 ).
In vivo bioimaging Preparation of the splenocytes for adoptive transfer was first accomplished by removing the spleen aseptically from FVB transgenic mice. Single-cell suspensions were made by forcing the tissue through a cell strainer with a sterile syringe plunger. Erythrocytes were removed using a RBC lysing buffer. Splenocytes, 4×10 6 were resuspended in 100 μl of saline and adoptively transferred i. v. into treatment animals. Mice were imaged using the Xenogen IVIS™50 system. In order to image live animals, mice were anesthetized by i.p. injection with 230 mg/kg of avertin to allow quick anesthesia and recovery time. Mice were then injected i.p. with 150 μl of luciferin (28.5 mg/ml, substrate for imaging) and imaged using the Xenogen bioimager as described (Ohlfest et al. 2005) . Luciferase positive splenocytes were quantitated in vivo by deriving a gate around the spleen, CNS, or whole animal measuring photon emittance using IgorPro 4.09A software (Alameda CA). Mice were imaged both 1 h and 24 h post-adoptive transfer with no significant difference in trafficking pattern. The results represent data obtained 1 h post adoptive transfer.
In vitro luciferase expression Under 2 ml/kg of Ketamine/ Xylazine anesthesia, mice were cardially perfused with 0.1 M phosphate saline buffer solution. Freshly separated brain tissue was homogenized with 1x cell culture lysis reagent (Promega, Madison, WI). Cell debris was removed after centrifugation at 10,000 × g for 5 min. Twenty μl of supernatant of brain lysate was mixed with 100 μl of luciferin substrate (Promega, Madison, WI). Luciferase expression on brain homogenates was measured by luminometer, lumat LB 9507 (Berthold Technologies, Oak Ridge, TN). Protein concentration of the brain homogenates was determined by Quick start Bradford protein assay kit (Bio-Rad, Hercules, CA). Brain homogenate protein levels were normalized in order to assess luciferase activity by measurement by the luminometer.
Statistical analysis Statistical comparisons were made by ANOVA, followed by ad hoc comparisons using a 2-tailed ttest. Differences in animal survival were evaluated by log-rank test. All tests were performed with Prism 4 software (Graph Pad Software, Inc). P values <0.05 were considered significant.
Results
While extensive research on the effects of morphine on the immune system has provided convincing evidence on morphine's immunomodulatory effects on immune responses (Roy et al. 2004; Gomez-Flores and Weber 1999; Olin et al. 2007; Yokota et al. 2000) , the effects of opiates on immune cell trafficking remains undetermined. Recently, the ability to follow "in vivo" trafficking patterns of luciferase transfected cells (Sweeney et al. 1999; Rauch et al. 2009; Ohlfest et al. 2005 ) has made it possible to determine potential effects of morphine on lymphocyte trafficking.
Morphine's effects on splenocyte trafficking We first examined in vivo effects of morphine dependence on splenocyte trafficking. This was accomplished by adoptively transferring firefly luciferase positive splenocytes into morphine dependent animals. Mice were imaged 1 h post adoptive. Luciferase positive splenocyte homed directly into the spleens in mice administered a placebo pellet (Fig. 1a) . In contrast, morphine significantly modulated the trafficking of fFL + splenocytes back into the spleen (Fig. 1b) . Moreover, morphine dependence induced diffuse trafficking of fFL + splenocytes throughout the animal (n=10). To quantify the alterations in extrasplenic trafficking, photon measurements were taken from the spleen and were subtracted from measurements taken from the remainder (Fig. 1c) and increased extrasplenic trafficking (ANOVA P=0.009, T test P=0.004) (Fig. 1d) throughout the animals.
Morphine's effect on CNS infiltration With the random trafficking observed in morphine dependent mice, we next wanted to determine if splenocytes infiltrated the CNS. Placebo or morphine dependent mice were adoptively transferred fFL + splenocyte and imaged 1 h later. Morphine dependence significantly increased splenocyte infiltration into the CNS (ANOVA P=0.004, T test P=0.002) compared to non-dependent mice (Fig. 2a & b) . To verify that photon emission was occurring from cells in the brain parenchyma, mice were perfused, brain lysates were made from nonmorphine and morphine dependent mice and assayed for luciferase activity. This validated that fFL + lymphocyte infiltrated the parenchyma of the CNS and were not in circulation giving false imaging results (ANOVA P=0.0006, T test P=0.002) (Fig. 2c ).
Morphine's effect on splenocyte infiltration-opioid receptor mediated? While there are three different opioid receptors, the majority of immunosuppressive effects of morphine or endogenous opioid release is mediated through the mu-receptor (Shavit et al. 1984; Gavériaux-Ruff et al. 1998; Yin et al. 1999; Mace et al. 2002; Wang et al. 2002a, b; Philippe et al. 2003) . To determine if the alterations in splenocyte trafficking were morphine mediated, mice were implanted with the opiate antagonist naltrexone in conjunction with morphine. Blocking the opioid-receptor with naltrexone significantly increased homing into the spleen (ANOVA P=0.0008, T test P=0.02) and inhibited splenocyte trafficking into CNS (ANOVA P=0.002, T test . To verify that photon emission was occurring from cells in the brain parenchyma, mice were perfused, brain lysates were made from placebo, morphine, and naltrexone +morphine mice and lysates were assayed for luciferase activity (Fig. 3c) . Morphine significantly increased luciferase activity in the CNS (ANOVA P=0.001, T test P=0.001), while blocking the opioid-receptor with naltrexone decreased luciferase activity (P=0.04). This experiment concluded that morphine induced CNS infiltration was opioid receptor mediated.
Morphine exacerbates CNS infiltration following neuroinflammation Endogenous and exogenous opioids exert physiologic effects on the CNS, via opioid receptors expressed within the CNS Heagy et al. 1990; Wang et al. 1994; Li et al. 1993; Yasuda et al. 1993 ).
We next investigated morphine's effect on splenocyte trafficking into the CNS following a neurostimulus. To accomplish this, placebo or morphine-dependent mice were intracerebrally injected with plasmid DNA/PEI complexes encoding IFN-γ. Morphine-dependent mice inoculated with empty plasmid were used as a control. To validate that the splenocytes were entering the CNS, mice were perfused and brains were assayed for luciferase activity. Inoculating placebo treated mice with an empty vector did not induce splenocyte trafficking into the CNS (Fig. 4a) , in contrast, placebo mice inoculated with IFN-γ plasmid induced splenocyte infiltration into the CNS (Fig. 4b) . As demonstrated above, splenocyte infiltration was increased in morphine dependent mice following a neurostimulus (Fig. 4c) . To determine if morphine exposure significantly increased CNS infiltration, photon emission and luciferase activity (ANOVA P=0.001 and P=0.01 respectively) were calculated revealing a statistically significant difference between the placebo treated empty vector control and IFN-γ plasmid (Photon P=0.02, Luc activity P=0.03) and placebo and morphine dependent mice (photon P=0.005, Luc activity P=0.04) inoculated with the IFN-γ producing plasmid (Figs. 4d & e) .
Discussion
Overwhelming evidence exists from in vitro, in vivo animal models, and from human clinical cases, that drugs of abuse profoundly affect nearly every component of the immune system with corresponding impact on the pathogenesis of infectious disease processes (Eisenstein and Hilburger 1998) . While it is well accepted that the increase in disease following injection drug use is primarily due to their modulatory effects on immune functions (Bryant et al. 1991; Gomez-Flores and Weber 1999; Olin et al. 2004; Yokota et al. 2000) little is known on the effects of opiates on immune cell trafficking. The study presented is the first to use in vivo imaging to delineate the possible effects opiates have on immune cell trafficking. We first sought to determine morphine's effects on nonspecific trafficking of splenocytes. In these experiments, morphine dependence significantly reduced splenocyte homing to the spleen following adoptive transfer. In fact, morphine dependence led to extrasplenic trafficking throughout the animal, noticeably, into the cervical, inguinal, and mesenteric lymph nodes.
It has been hypothesized that HIV attaches to and is carried in monocytes and CD4 T cells as a passenger of a E. Luciferase activity from the CNS. Error bars indicate +/− STE "Trojan horse" (Wiley et al. 1986; Jordan et al. 1991) . While the Trojan horse theory remains a distinct possibility, entry across the highly regulated blood brain barrier is still required. In the present study, there was a significant infiltration of splenocytes into the CNS in morphine dependent mice without a neurostimulus. The non-directed splenocyte infiltration into the CNS may be particularly relevant for tuberculosis, HIV, and other pathogens, providing a vehicle for entry into the CNS. While the mechanism of the non-antigen directed CNS infiltration remains unknown, one possible mechanism may be due systemic immune activation such as occurs in sepsis, which has been previously demonstrated in animal models (Hilburger et al. 1997; Roy et al. 1999) .
Opiates have profound modulatory effects on nearly every cell of the immune system (Donahoe and Falck 1990) . While it has been demonstrated that opiates affect trafficking in an antigen non-specific manner (Hilburger et al. 1997; Roy et al. 1999) , the vast majority of opiate dependent effects alter immune function following an antigen stimulus. In the presented study, a neuroinflammatory response was implemented using an in vivo transfection system (Wu et al. 2007 ) using a plasmid engineered to continuously produce IFN-γ. A significant infiltration of fFL + splenocytes was detected in IFN-γ treated animals. To control for injection alone mediating an inflammatory response, a group of mice were inoculated with a non-IFN-γ producing plasmid, which failed to induce detectable CNS infiltration.
Splenocyte infiltration following a neuroinflammatory response allowed us to answer the question of whether opiates modulate splenocyte trafficking into the CNS. While there was a statistically significant splenocyte infiltration into the CNS following morphine dependence, this response was exacerbated following induction of IFN-γ production. In conclusion, the study presented was the first to use an in vivo imaging system to delineate the trafficking pattern of splenocyte homing in morphine dependent mice, revealing that morphine dependence had a profound effect on splenocyte infiltration into the CNS. Morphine dependent mice had a dramatic infiltration of splenocytes into the CNS without the need of a neurostimulus. This infiltration is one possible mechanism for viral entry into the CNS initiating a neuroinflammatory response in opiate drug abusers.
